Vorrichtungen und Verfahren zur Abgabe von Therapeutischen Flüssigkeiten

Details

Veröffentlichungs-Nr.

EP4714480

Anmeldetag

1. September 2021

Veröffentlichung

25. März 2026

Rechtsraum

EP

IPC

A61M5/20, A61M5/315, A61M5/32A61M5/32(LILLY CO ELI et al.)(CONSORT MEDICAL PLC et al.)(GUILLERMO CARLOS et al.)

Abstract

A therapeutic agent delivery system includes a therapeutic agent delivery assembly carried by a housing. The therapeutic agent delivery assembly includes a chamber including a first passageway, a therapeutic agent carried in the first passageway, and a needle in communication with the first passageway. The therapeutic agent delivery assembly is translatable relative to the housing from a stowed configuration to a deployed configuration. In the deployed configuration the needle at least partially extends distally from the distal end portion of the housing. The therapeutic agent delivery assembly is translatable relative to the housing from the deployed configuration to a retracted configuration. In the retracted configuration the needle is disposed proximally relative to the distal end portion of the housing. A drive mechanism translates the therapeutic agent delivery assembly from the stowed configuration to the deployed configuration and from the deployed configuration to the retracted configuration.

Anmelder

Firma

Eli Lilly and Company

Land

🇺🇸 USA